- Home
- ETON vs BNTC Comparison
ETON vs BNTC Comparison
Compare ETON & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- BNTC
- Stock Information
- Founded
- ETON 2017
- BNTC 1995
- Country
- ETON United States
- BNTC United States
- Employees
- ETON N/A
- BNTC N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ETON Health Care
- BNTC Health Care
- Exchange
- ETON Nasdaq
- BNTC Nasdaq
- Market Cap
- ETON 329.8M
- BNTC 339.8M
- IPO Year
- ETON 2018
- BNTC N/A
- Fundamental
- Price
- ETON $15.58
- BNTC $14.97
- Analyst Decision
- ETON Strong Buy
- BNTC Strong Buy
- Analyst Count
- ETON 3
- BNTC 7
- Target Price
- ETON $24.00
- BNTC $24.43
- AVG Volume (30 Days)
- ETON 244.0K
- BNTC 32.9K
- Earning Date
- ETON 05-08-2025
- BNTC 05-12-2025
- Dividend Yield
- ETON N/A
- BNTC N/A
- EPS Growth
- ETON N/A
- BNTC N/A
- EPS
- ETON N/A
- BNTC N/A
- Revenue
- ETON $34,677,000.00
- BNTC N/A
- Revenue This Year
- ETON $22.19
- BNTC N/A
- Revenue Next Year
- ETON $109.55
- BNTC N/A
- P/E Ratio
- ETON N/A
- BNTC N/A
- Revenue Growth
- ETON 5.64
- BNTC N/A
- 52 Week Low
- ETON $3.03
- BNTC $4.75
- 52 Week High
- ETON $18.41
- BNTC $15.29
- Technical
- Relative Strength Index (RSI)
- ETON 53.40
- BNTC 70.53
- Support Level
- ETON $14.28
- BNTC $11.99
- Resistance Level
- ETON $15.02
- BNTC $13.00
- Average True Range (ATR)
- ETON 0.93
- BNTC 1.03
- MACD
- ETON -0.00
- BNTC 0.34
- Stochastic Oscillator
- ETON 79.52
- BNTC 94.17
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.